Mediterranean Journal of Medical Research (Mediterr J Med Res., ISSN: 3080-7735) is an international online journal in English published "quarterly" for scientists and research scholars involved in Medical Sciences and all other related areas of medicine. Manuscripts reporting original research, general articles, case reports, and innovative applications from all parts of the world are welcome. Manuscripts for publication in Mediterr J Med Res are selected through rigorous peer review to ensure originality, timeliness, relevance, and reliability. The main aim of Mediterr J Med Res is to publish peer-reviewed research and review articles in the rapidly developing field of Medicine and Medical Research. MJMR is an online journal with full access to research and review papers. The journal also seeks ideal surveys and review articles from experts to promote an insightful understanding of the current trends. Mediterr J Med Res aims to cover the latest outstanding developments in the field of Medical Research.
Manuscripts should be addressed to Editor-in-Chief: abdulgbaj1@hotmail.com / Fmosherif@yahoo.com
All the contents of this journal are licensed under a Creative Commons Attribution 4.0 International License.
Google Scholar معامل التأثير العربي 
Directory of Online Libyan Journals
Publishing timeline
- 15 days: Time to first decision
- 45 days: Review time
- 60 days: Submission to acceptance
- 15 days: Acceptance to publication
Acceptance rate: 67.02%
Volume 3, Issue 2, 2026 June
3(2), 2026 June
Review
Highlight https://doi.org/10.5281/zenodo.19373711
Mediterr J Med Res, vol.3 n2, 137-146, June, 2026, Publication date April 01, 2026 CRISPR-Cas9-based functional analysis of PARP inhibitor response in BRCA-mutated breast cancer and its implications for precision pharmacogenomics BRCA1/BRCA2 mutations, PARP inhibitor resistance, precision therapy, synthetic lethality ReviewMolecular biology
Mediterr J Med Res, vol.3 n2, 137-146, June, 2026, Publication date April 01, 2026 CRISPR-Cas9-based functional analysis of PARP inhibitor response in BRCA-mutated breast cancer and its implications for precision pharmacogenomics BRCA1/BRCA2 mutations, PARP inhibitor resistance, precision therapy, synthetic lethality ReviewMolecular biology
Short communication
Highlight Mediterr J Med Res, vol.3 n2, 147-151, June, 2026, Publication date April 05, 2026 The extent of Libyan society’s awareness of the importance of pre-marital medical examination
Health awareness, hereditary diseases, healthy marriage, university students
Short communicationPublic Health
Prof. Abdul M Gbaj
Periodicity: Quarterly
Published by: Libyan Association for Pharmacists
Most Viewed
Most downloaded
